Edgar Jannotta, a former GTCR managing principal, is one of the investors in the orthopedic device company.
All parties are looking to ArthroCAD to develop safer, more accurate implants for THA.
More Articles on Devices:
Zimmer to Close Austin Device Plant in July
MAKO Surgical Gives $265k Research Grant to Rebound Orthopedics & Neurosurgery
AxioMed Spine Collects $3.6M in Device Development Funding
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.